Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cefpiramide Sodium
2. Cefpiramide, Sodium Salt
3. Sm 1652
4. Sm-1652
5. Sumcefal
1. 70797-11-4
2. Cefpiramide Acid
3. Cefpiramido
4. Cefpiramidum
5. Wy-44635
6. Wy-44,635
7. (6r,7r)-7-[[(2r)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1h-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
8. Chebi:59213
9. P936ya152n
10. Nsc-759869
11. Ncgc00167444-01
12. Sm 1652
13. Sm-1652
14. (7r)-7-[[(2r)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1h-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
15. (6r,7r)-7-((r)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
16. Wy 44,635
17. Cefpiramidum [inn-latin]
18. Cefpiramido [inn-spanish]
19. Unii-p936ya152n
20. Cefpiramide [usan:usp:inn]
21. Wy 44635
22. Cefpiramide (usp/inn)
23. Cefpiramide [mi]
24. Cefpiramide [inn]
25. Cefpiramide [usan]
26. Cefpiramide [mart.]
27. Dsstox_cid_26630
28. Dsstox_rid_81778
29. Dsstox_gsid_46630
30. Schembl49253
31. Cefpiramide [usp-rs]
32. Cefpiramide [who-dd]
33. Chembl1201204
34. Dtxsid6046630
35. Gtpl12027
36. Cefpiramide [usp Impurity]
37. Hms3715h12
38. Hy-b1354
39. Zinc4215257
40. Tox21_112448
41. Mfcd00864893
42. S5186
43. Akos025311237
44. Ccg-221235
45. Db00430
46. Nsc 759869
47. Ncgc00167444-04
48. (6r,7r)-7-((r)-2-(4-hydroxy-6-methylnicotinamido)-2-(p-hydroxyphenyl)acetamido)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
49. As-14170
50. Cas-70797-11-4
51. Cs-0013097
52. D03428
53. 797c114
54. Q4921174
55. Brd-k92872987-001-02-9
56. Cefpiramide Acid;cefpiramido;cefpiramidum;wy-44635;sm-1652
57. (6r,7r)-7-((r)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
58. (6r,7r)-7-[(2r)-2-[(4-hydroxy-6-methylpyridin-3-yl)formamido]-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1h-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
59. (6r,7r)-7-{[(2r)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
60. (7r)-7-((r)-2-(4-hydroxy-6-methylnicotinamido)-2-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1h-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
61. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((((4-hydroxy-6-methyl-3-pyridinyl)carbonyl)amino)(4-hydroxyphenyl)acetyl)amino)-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, (6r-(6alpha,7beta(r*)))-
62. 7beta-[(2r)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido]-3-{[(1-methyl-1h-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic Acid
| Molecular Weight | 612.6 g/mol |
|---|---|
| Molecular Formula | C25H24N8O7S2 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 9 |
| Exact Mass | 612.12093748 g/mol |
| Monoisotopic Mass | 612.12093748 g/mol |
| Topological Polar Surface Area | 259 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 1270 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For treatment of severe infections caused by susceptible bacteria such as P. aeruginosa.
Cefpiramide is a cephalosporin active against Pseudomonas aeruginosa. It has a broad spectrum of antibacterial activity. Cefpiramide works by inhibiting bacterial cell wall biosynthesis. The plasma half-lives of cefpiramide in rabbits, dogs, and rhesus monkeys were much longer than those of cefoperazone and cefazolin.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DD - Third-generation cephalosporins
J01DD11 - Cefpiramide
Absorption
Rapidly absorbed following intramuscular injection.
4.44 hours
The bactericidal activity of cefpiramide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Cefpiramide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefpiramide, including repackagers and relabelers. The FDA regulates Cefpiramide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefpiramide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefpiramide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefpiramide supplier is an individual or a company that provides Cefpiramide active pharmaceutical ingredient (API) or Cefpiramide finished formulations upon request. The Cefpiramide suppliers may include Cefpiramide API manufacturers, exporters, distributors and traders.
click here to find a list of Cefpiramide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cefpiramide DMF (Drug Master File) is a document detailing the whole manufacturing process of Cefpiramide active pharmaceutical ingredient (API) in detail. Different forms of Cefpiramide DMFs exist exist since differing nations have different regulations, such as Cefpiramide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cefpiramide DMF submitted to regulatory agencies in the US is known as a USDMF. Cefpiramide USDMF includes data on Cefpiramide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cefpiramide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cefpiramide suppliers with USDMF on PharmaCompass.
Cefpiramide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefpiramide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefpiramide GMP manufacturer or Cefpiramide GMP API supplier for your needs.
A Cefpiramide CoA (Certificate of Analysis) is a formal document that attests to Cefpiramide's compliance with Cefpiramide specifications and serves as a tool for batch-level quality control.
Cefpiramide CoA mostly includes findings from lab analyses of a specific batch. For each Cefpiramide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefpiramide may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefpiramide EP), Cefpiramide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefpiramide USP).
LOOKING FOR A SUPPLIER?
